MIT researchers outfitted a Boston Dynamics robotic dog with contactless vital sign monitoring equipment to help clinicians care for patients with Covid-19 without risking exposure, reports Darrell Etherington for TechCrunch. Etherington writes that the system “has the potential to not only reduce the risk of exposure for medical personnel, but also drastically reduce use of personal protective equipment.”
Writing for The New Yorker, Bernard Avishai spotlights Prof. Andrew Lo’s work exploring the need for a revolution in financial engineering to help spur the development of vaccines, and how a vaccine megafund could have assisted in bringing the Covid-19 pandemic under control. “The more I studied this, the more I realized that finance actually plays a huge role in drug development,” says Lo, “in many cases, way too big a role.”
Researchers from the Singapore-MIT Alliance for Research and Technology have “discovered a way to increase antimicrobial sensitivity in bacteria by exposing them to hydrogen sulphide (H2S),” reports Health Europa.
WHDH spotlights MIT startup E25Bio, which is developing a new rapid test to diagnose Covid-19. The test being developed by E25Bio is a paper strip that can deliver test results in 15 minutes, WHDH explains.
Prof. James Collins speaks with Molly Wood of Marketplace about his work developing a faster, cheaper and more accurate Covid-19 diagnostic. Collins explains that his research group is “using synthetic biology to create highly sensitive, low-cost diagnostics, some that are now approved for use in clinical diagnostics labs, and now we’re moving towards point-of-care diagnostics, as well as at-home diagnostics.”
Reporting for USA Today, Karen Weintraub spotlights how researchers from MIT and 3M are collaborating on a rapid, low-cost diagnostic test for Covid-19. "The world needs as many useful tests as possible as fast as possible," says Prof. Hadley Sikes.
Reporting for CNN, Scottie Andrew highlights how researchers from MIT and Brigham and Women’s Hospital developed the iMASC, a silicon mask that can be reused and sterilized multiple times. Andrew notes that the mask is “a promising step toward addressing the critical healthcare supply shortages.”
Writing for The Washington Post, Prof. Robin Wolfe Scheffler underscores the importance of not only pursuing coronavirus vaccine development initiatives, but also “addressing the social and political factors that exacerbate disease and limit the access of many Americans to basic medical care.”
Prof. Sangeeta Bhatia and senior postdoctoral associate Leslie Chan discuss their work developing a synthetic biosensor to diagnose lung disease. Chan explains that “instead of relying on naturally occurring breath volatiles, we wanted to be able to engineer the breath signal that we could use to monitor lung disease.”
CNBC reporter Cory Stieg writes about how researchers from MIT and Brigham and Women’s Hospital created a new reusable silicon mask with slots for small disposable N95 filters. “The masks themselves can be quickly and easily sterilized and reused, and though the small filters must be thrown out, each mask requires much less N95 material,” writes Stieg.
Reuters reporter Storay Karimi spotlights how the Afghan all-girls robotics team has designed a low-cost ventilator, based in part off the E-Vent device developed by MIT researchers.
Fast Company reporter Adele Peters writes that researchers from MIT and Brigham and Women’s Hospital have developed a new face mask that is made of silicon and designed to be reused and sterilized repeatedly. “We wanted to have a system that could be accessible and used by anyone globally,” says Prof. Giovanni Traverso
CNBC reporter Will Feur spotlights how researchers from MIT are working with 3M on developing a rapid coronavirus antigen test. The test “will be a paper-based point-of-care testing device, which will help reduce the cost,” Feur explains.
Researchers from MIT and 3M are developing a new rapid antigen test for Covid-19, reports Carl O’Donnell for Reuters. “The test would produce results within minutes and could be administered on a low-cost, paper-based device, similar to a home pregnancy test, that could be delivered at the point of care,” writes O’Donnell.
TechCrunch reporter Darrell Etherington writes that researchers from MIT and 3M are working on creating a new diagnostic tool for Covid-19 that can be manufactured cheaply and in large volumes for mass distribution. “The goal is to create a test that detects viral antigens,” Etherington explains, adding that the tests “provide results much faster than the molecular PCR-based test.”